Diabetes noninvasive therapeutic apparatus

Abstract

The invention relates to a non-invasive therapeutic instrument for diabetes mellitus, which comprises a static magnetic probe used for generating a static magnetic field under the control of a static magnetic control signal, a dynamic magnetic probe used for generating an alternating magnetic field under the control of a dynamic magnetic control signal, and a gyromagnetic probe used for generating a rotating magnetic field under the control of a gyromagnetic control signal, the non-invasive therapeutic apparatus for diabetes further comprises a heart rate detection module which is used for detecting the heart rate of a user and outputting a heart rate detection signal; the control module is used for outputting a static magnetic control signal, a dynamic magnetic control signal and a gyromagnetic control signal, and the control module is further used for outputting a pulse control signal according to the received heart rate detection signal; the pulse magnetic probe is used for generating a pulse alternating magnetic field with the frequency equal to the heart rate of the user according to the received pulse control signal. The pulse alternating magnetic field which is variable in frequency and adapts to the human body acts on the human body, the acting effect can be improved, and standard management and treatment of diabetes mellitus are achieved.

Description

Technical Field

[0001] The present invention relates to the field of medical devices, and in particular to a non-invasive treatment device for diabetes. Background Art

[0002] In recent years, the number of diabetic patients has been increasing year by year, and the demand for standardized management and treatment of diabetic patients has also been increasing. At present, there are products that use magnetic fields to treat diabetes, but these products currently use magnetic fields with set parameters to act on the human body, and their treatment effects are not ideal. Summary of the invention

[0003] The purpose of the present invention is to provide a non-invasive diabetes treatment device that can improve the treatment effect.

[0004] In order to achieve the above object, the technical solution adopted by the present invention is: A non-invasive treatment device for diabetes, comprising a static magnetic probe for generating a static magnetic field under the control of a static magnetic control signal, a dynamic magnetic probe for generating an alternating magnetic field under the control of a dynamic magnetic control signal, and a gyromagnetic probe for generating a rotating magnetic field under the control of a gyromagnetic control signal, the non-invasive treatment device for diabetes also comprising: A heart rate detection module, which is used to detect the user's heart rate and output a heart rate detection signal; A control module, the control module is used to output the static magnetism control signal, the dynamic magnetism control signal and the gyromagnetism control signal, and the control module is also used to output a pulse control signal according to the received heart rate detection signal; A pulse magnetic probe, the pulse magnetic probe is used to generate a pulse alternating magnetic field with a frequency equal to the heart rate of the user according to the received pulse control signal; The heart rate detection module, the static magnetic probe, the dynamic magnetic probe, the gyromagnetic probe, and the pulse magnetic probe are respectively connected to the control module.

[0005] The control module is connected to the pulse magnetic probe via a first probe driving interface module, and the control module is connected to the static magnetic probe, the dynamic magnetic probe, and the gyromagnetic probe via a second probe driving interface module.

[0006] The non-invasive treatment device for diabetes comprises two pulse magnetic probes, four static magnetic probes, two dynamic magnetic probes and one gyromagnetic probe.

[0007] The non-invasive diabetes treatment device also includes: A temperature detection module, the temperature detection module is used to detect the temperature of the contact surface between the pulse magnetic probe and the user and output a temperature detection signal; The temperature detection module is connected to the control module, and the control module is further used to output the pulse control signal according to the received temperature detection signal.

[0008] The non-invasive diabetes treatment device also includes: A power-on authentication module, the power-on authentication module is used to identify different users; An information storage module, the information storage module is used to store the relevant information of the user; An information output module, the information output module is used to output relevant information of the user; The power-on authentication module, the information storage module, and the information output module are respectively connected to the control module.

[0009] The power-on authentication module is an iris recognition module.

[0010] The non-invasive diabetes treatment device also includes: A wireless communication module is connected to the control module and is used to realize wireless communication between the control module and a host computer and / or between the control module and an intelligent terminal.

[0011] The non-invasive diabetes treatment device also includes: The voice control module is used to acquire voice and convert it into a voice signal and then send it to the control module.

[0012] The non-invasive diabetes treatment device also includes: A non-invasive blood glucose measurement module is used to measure the blood glucose level of the user in a non-invasive manner and output a blood glucose measurement signal to the control module.

[0013] The control module is arranged in the host, and the heart rate detection module, the static magnetic probe, the dynamic magnetic probe, the gyromagnetic probe, and the pulse magnetic probe are respectively connected to the host through a plug-in interface.

[0014] Due to the application of the above technical solution, the present invention has the following advantages compared with the prior art: the present invention acts on the human body through a pulsed alternating magnetic field with a variable frequency that adapts to the human body, which can improve the effect and achieve standardized management and treatment of diabetes. BRIEF DESCRIPTION OF THE DRAWINGS

[0015] Attached Figure 1 The figure is a principle block diagram of the non-invasive diabetes treatment device of the present invention. DETAILED DESCRIPTION

[0016] The present invention will be further described below in conjunction with the embodiments shown in the accompanying drawings.

[0017] Embodiment 1: As shown in the attached Figure 1 As shown, a non-invasive treatment device for diabetes includes a control module, a plurality of static magnetic probes, a plurality of dynamic magnetic probes, a plurality of gyromagnetic probes, a plurality of pulse magnetic probes and a heart rate detection module. The heart rate detection module, the static magnetic probe, the dynamic magnetic probe, the gyromagnetic probe and the pulse magnetic probe are respectively connected to the control module. The control module is connected to the pulse magnetic probe through a first probe driving interface module, and the control module is connected to the static magnetic probe, the dynamic magnetic probe and the gyromagnetic probe through a second probe driving interface module.

[0018] The heart rate detection module is used to detect the user's heart rate and output a heart rate detection signal to the control module. The control module is used to output a static magneto control signal, a dynamic magneto control signal and a gyromagnetic control signal to the static magneto probe, the dynamic magneto probe and the gyromagnetic probe respectively. The control module is also used to output a pulse control signal to the pulse magnetic probe according to the received heart rate detection signal. The static magneto probe is used to generate a static magnetic field under the control of the static magneto control signal (for example, a static magnetic field that is 100 times the background magnetic field of the earth), the dynamic magneto probe is used to generate an alternating magnetic field under the control of the dynamic magneto control signal (for example, an alternating magnetic field of 50Hz), and the gyromagnetic probe is used to generate a rotating magnetic field under the control of the gyromagnetic control signal (for example, a rotating magnetic field of 10Hz, 500 times the background magnetic field of the earth). The pulse control signal output by the control module includes magnetic field frequency information, so that the pulse magnetic probe is used to generate a pulse alternating magnetic field according to the received pulse control signal, and the frequency of the pulse alternating magnetic field is equal to the user's heart rate (for example, a pulse alternating magnetic field that is 500 times the geomagnetic intensity).

[0019] In addition, the non-invasive treatment device for diabetes also includes a temperature detection module connected to the control module, and the temperature detection module is used to detect the temperature of the contact surface between the pulse magnetic probe and the user and output a temperature detection signal to the control module. The control module is also used to output a pulse control signal according to the received temperature detection signal, and the pulse control signal output by the control module also includes magnetic field strength information, so that the pulse magnetic probe is used to generate a pulse alternating magnetic field of corresponding strength according to the received pulse control signal. When the temperature detection module detects that the temperature of the contact surface between the pulse magnetic probe and the user increases, the intensity of the pulse alternating magnetic field generated by the pulse magnetic probe is controlled to decrease. The above-mentioned temperature-based magnetic field strength control can be achieved according to a preset functional relationship.

[0020] The above-mentioned non-invasive treatment device for diabetes includes 2 pulse magnetic probes, 4 static magnetic probes, 2 dynamic magnetic probes and 1 rotary magnetic probe. The first pulse magnetic probe acts on the Dazhui point from the back of the human body, and the second pulse magnetic probe acts on the vicinity of the Shenque point from the front of the human body. The first static magnetic probe acts on the Qimen point and Riyue point on the left side from the front of the human body, the second static magnetic probe acts on the Qimen point and Riyue point on the right side from the front of the human body, the third static magnetic probe acts on the Shenshu point on the left side from the back of the human body, and the fourth static magnetic probe acts on the Shenshu point on the right side from the back of the human body. The two dynamic magnetic probes act on the left and right Zusanli points or the left and right Yongquan points respectively. The rotary magnetic probe acts on the Mingmen point from the back of the human body.

[0021] Based on the above scheme, the non-invasive diabetes treatment device can also include one or more of the following modules: 1. Power-on authentication module. The power-on authentication module is connected to the control module and is used to identify different users under the control of the control module. The power-on authentication module can use an iris recognition module or a code scanning module to identify different users by scanning codes. Identifying different users can create treatment files for different users and track treatment effects; 2. Information storage module. The information storage module is connected to the control module and is used to store relevant information of the user, such as the above-mentioned treatment files, for the user to query under the control of the control module; 3. Information output module. The information output module is connected to the control module and is used to output the user's relevant information. When the user queries his information, it is output through the information output module. The information output module can use a display screen with interactive functions, or a combination of a display screen and a keypad; 4. Wireless communication module. The wireless communication module is connected to the control module and is used to realize wireless communication between the control module and the host computer and / or between the control module and the intelligent terminal, so as to realize information uploading; 5. Voice control module. The voice control module is used to obtain voice and convert it into voice signals and then send them to the control module, making it convenient for users to operate the therapeutic device; 6. Non-invasive blood glucose measurement module. The non-invasive blood glucose measurement module is used to measure the user's blood glucose level in a non-invasive manner and output a blood glucose measurement signal to the control module. The non-invasive blood glucose measurement module can be used to conveniently monitor the user's blood glucose to evaluate the treatment effect.

[0022] The above-mentioned non-invasive diabetes treatment device can be provided with a host, and the control module is provided in the host. Several plug-in interfaces are provided on the host, and the heart rate detection module, static magnetic probe, dynamic magnetic probe, rotary magnetic probe, and pulse magnetic probe are connected to the host through the plug-in interfaces respectively, which is convenient for use and storage. A power module is provided in the host, which is used to convert the external power supply into the working power supply and supply power to the control module and other parts.

[0023] The above-mentioned non-invasive diabetes treatment device can achieve better treatment effects by automatically and dynamically adjusting the frequency of the alternating magnetic field according to the user's heart rate, replacing the original fixed-frequency alternating magnetic field.

[0024] The above embodiments are only for illustrating the technical concept and features of the present invention, and their purpose is to enable people familiar with the technology to understand the content of the present invention and implement it accordingly, and they cannot be used to limit the protection scope of the present invention. Any equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention.

Claims

1. A non-invasive treatment device for diabetes, comprising a static magnetic probe for generating a static magnetic field under the control of a static magnetic control signal, a dynamic magnetic probe for generating an alternating magnetic field under the control of a dynamic magnetic control signal, and a gyromagnetic probe for generating a rotating magnetic field under the control of a gyromagnetic control signal, characterized in that: The non-invasive diabetes treatment device also includes: A heart rate detection module, which is used to detect the user's heart rate and output a heart rate detection signal; A control module, the control module is used to output the static magnetism control signal, the dynamic magnetism control signal and the gyromagnetism control signal, and the control module is also used to output a pulse control signal according to the received heart rate detection signal; A pulse magnetic probe, the pulse magnetic probe is used to generate a pulse alternating magnetic field with a frequency equal to the heart rate of the user according to the received pulse control signal; The heart rate detection module, the static magnetic probe, the dynamic magnetic probe, the gyromagnetic probe, and the pulse magnetic probe are respectively connected to the control module.

2. The non-invasive treatment device for diabetes mellitus according to claim 1, characterized in that: The control module is connected to the pulse magnetic probe via a first probe driving interface module, and the control module is connected to the static magnetic probe, the dynamic magnetic probe, and the gyromagnetic probe via a second probe driving interface module.

3. The non-invasive treatment device for diabetes mellitus according to claim 1, characterized in that: The non-invasive treatment device for diabetes comprises two pulse magnetic probes, four static magnetic probes, two dynamic magnetic probes and one gyromagnetic probe.

4. The non-invasive treatment device for diabetes mellitus according to claim 1, characterized in that: The non-invasive diabetes treatment device also includes: A temperature detection module, the temperature detection module is used to detect the temperature of the contact surface between the pulse magnetic probe and the user and output a temperature detection signal; The temperature detection module is connected to the control module, and the control module is further used to output the pulse control signal according to the received temperature detection signal.

5. The non-invasive treatment device for diabetes mellitus according to claim 1, characterized in that: The non-invasive diabetes treatment device also includes: A power-on authentication module, the power-on authentication module is used to identify different users; An information storage module, the information storage module is used to store relevant information of the user; An information output module, the information output module is used to output relevant information of the user; The power-on authentication module, the information storage module, and the information output module are respectively connected to the control module.

6. The non-invasive treatment device for diabetes mellitus according to claim 5, characterized in that: The power-on authentication module is an iris recognition module.

7. The non-invasive treatment device for diabetes mellitus according to claim 1, characterized in that: The non-invasive diabetes treatment device also includes: A wireless communication module is connected to the control module and is used to realize wireless communication between the control module and a host computer and / or between the control module and an intelligent terminal.

8. The non-invasive treatment device for diabetes mellitus according to claim 1, characterized in that: The non-invasive diabetes treatment device also includes: The voice control module is used to acquire voice and convert it into a voice signal and then send it to the control module.

9. The non-invasive treatment device for diabetes mellitus according to claim 1, characterized in that: The non-invasive diabetes treatment device also includes: A non-invasive blood glucose measurement module is used to measure the blood glucose level of the user in a non-invasive manner and output a blood glucose measurement signal to the control module.

10. The non-invasive treatment device for diabetes mellitus according to claim 1, characterized in that: The control module is arranged in the host, and the heart rate detection module, the static magnetic probe, the dynamic magnetic probe, the gyromagnetic probe, and the pulse magnetic probe are respectively connected to the host through a plug-in interface.

Images